Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07478679 · ClinicalTrials.gov registry record · Phase 1
Radiation to Treat Joint Damage Caused by Cancer Immunotherapy
A Phase 1 study, sponsored by University of Chicago.
- Not yet
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT07478679 is a Phase 1 study that has not yet begun recruiting, run by University of Chicago. The registered enrollment target is 20 participants.
The verdict
NCT07478679, a Phase 1 study, has not yet begun recruiting, sponsored by University of Chicago.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study will prospectively investigate the feasibility and safety of administering LDRT in patients with immunotherapy-induced inflammatory arthritis.
Interventions
- RADIATION Low dose radiation therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-08-26 |
| Est. Completion | 2028-09-17 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07478679
The ClinicalTrials.gov registry entry for NCT07478679 describes a study currently listed as not yet recruiting, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Low dose radiation therapy is the first listed.
NCT07478679 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07478679 about?
NCT07478679 is a clinical study titled "Radiation to Treat Joint Damage Caused by Cancer Immunotherapy". This study will prospectively investigate the feasibility and safety of administering LDRT in patients with immunotherapy-induced inflammatory arthritis.
What is the current status of trial NCT07478679?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2026-08-26. Estimated completion is 2028-09-17.
What interventions are being tested in trial NCT07478679?
The interventions under investigation include: Low dose radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT07478679?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.